Company Encyclopedia
View More
name
BAMBOOSHEALTH
02293.HK
Bamboos Health Care Holdings Limited, an investment holding company, provides healthcare staffing solutions in Hong Kong. The company offers outreach case assessment; clinic; private nursing; home care and out-patient escorting; professional home care and rehabilitation assessment; palliative/hospice care at home; home safety assessment and modification; professional rehabilitation equipment rental; and physiotherapy and occupational therapy services. It also provides marketing and consulting services; and technology promotion and application services. In addition, the company engages in the sale of health-related merchandise; planning and organizing special events; retail business; and operation of vaccination centers.
52.63 B
02293.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care ServicesIndustry
Industry Ranking14/28
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE7.84%B
    • Profit Margin23.40%A
    • Gross Margin54.45%B
  • Growth ScoreD
    • Revenue YoY-21.52%E
    • Net Profit YoY-43.27%D
    • Total Assets YoY-0.68%D
    • Net Assets YoY5.06%B
  • Cash ScoreD
    • Cash Flow Margin427.39%C
    • OCF YoY-21.52%E
  • Operating ScoreD
    • Turnover0.24D
  • Debt ScoreB
    • Gearing Ratio27.39%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    BAMBOOSHEALTH will distribute a final dividend of HKD 0.015 per share on December 18

    According to the Zhitong Finance APP, BAMBOOSHEALTH announced that it will distribute a final dividend of HKD 0.015 per share for the year ending June 30, 2025, on December 18, 2025

    Zhitong·
    HK
    02293
    0.00%
    Zhitong·
    HK
    02293
    0.00%

    In the "Performance" report, BAMBOOSHEALTH's annual net profit is HKD 17.54 million, a decrease of 43.3%, with a final dividend of 1.5 cents

    BAMBOOSHEALTH announced its financial results for the fiscal year ending in June, with revenue of HKD 74.4 million, a year-on-year decline of 21.5%. It recorded a net profit of HKD 17.54 million, a decrease of 43.3%, with earnings per share of 4.38 cents. A final dividend of 1.5 cents was declared

    AASTOCKS·
    HK
    02293
    0.00%
    AASTOCKS·
    HK
    02293
    0.00%

    BAMBOOSHEALTH released its annual performance, with a net profit of HKD 17.541 million, a year-on-year decrease of 43.3%

    BAMBOOSHEALTH released its annual performance for the year ended June 30, 2025, with a net profit of HKD 17.541 million, a year-on-year decrease of 43.3%. Revenue from client contracts was HKD 74.404 million, a year-on-year decrease of 21.5%. The basic earnings per share were HKD 0.0438, and a final dividend of HKD 0.015 per share is proposed. The group is committed to attracting and retaining healthcare personnel, with approximately 32,000 registered healthcare personnel as of June 30, 2025, an increase of about 2,200 compared to last year

    Zhitong·
    HK
    02293
    0.00%
    Zhitong·
    HK
    02293
    0.00%

    BAMBOOSHEALTH: Deng Yihai appointed as independent non-executive director

    According to the announcement from BAMBOOSHEALTH, Mr. Lin Guoming has decided to dedicate more time to his personal commitments and has resigned as the company's independent non-executive director effective August 1, 2025. He will also no longer serve as the chairman of the company's remuneration committee, a member of the audit committee, and a member of the nomination committee. Effective August 1, 2025, Mr. Deng Yihai has been appointed as the company's independent non-executive director, chairman of the remuneration committee, a member of the audit committee, and a member of the nomination committee

    Zhitong·
    HK
    02293
    0.00%
    Zhitong·
    HK
    02293
    0.00%

    BAMBOOSHEALTH purchased a total of 8,600 shares of SPDR Gold ETF

    On April 14, 2025, BAMBOOSHEALTH purchased 8,600 shares of SPDR Gold ETF through the Hong Kong Stock Exchange, at a total cost of approximately HKD 19.97 million, or about HKD 2,322 per share. In the past 12 months, the group has purchased a total of 11,965 shares of SPDR Gold ETF, at a total cost of approximately HKD 22.2 million, or about HKD 1,855 per share. After the acquisition, the group holds 20,565 shares of SPDR Gold ETF, accounting for approximately 0.00632% of the total share capital

    Zhitong·
    HK
    02293
    0.00%
    Zhitong·
    HK
    02293
    0.00%
    © 2025 Longbridge｜Disclaimer